BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 892384)

  • 1. Pharmacotherapy of an ulcer in Barrett's esophagus: carbenoxalone and cimetidine.
    Thompson WG; Barr R
    Gastroenterology; 1977 Oct; 73(4 Pt 1):808-10. PubMed ID: 892384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barrett's ulcer and treatment with cimetidine.
    Kothari T; Mangla JC; Kalra TM
    Arch Intern Med; 1980 Apr; 140(4):475-7. PubMed ID: 7362376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symposium on peptic ulcer disease. 1. Medical treatment of peptic ulcer.
    Jeejeebhoy KN
    Can J Surg; 1978 Jan; 21(1):17-8. PubMed ID: 579607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current medical management of duodenal ulcer disease.
    Badley BW
    Can Med Assoc J; 1977 Nov; 117(10):1192-5. PubMed ID: 603851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged cimetidine therapy in ulcerated Barrett's columnar-lined esophagus.
    Delpre G; Kadish U; Glanz I; Avidor I
    Am J Gastroenterol; 1984 Jan; 79(1):8-11. PubMed ID: 6419585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barrett's ulcer.
    Maiorana A; Stephens JK; Little AG
    Am Surg; 1988 Mar; 54(3):178-9. PubMed ID: 3348553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenic heterogeneity of Barrett's ulcers. Apropos of 38 case reports].
    Ollyo JB; Fontolliet C; Monnier P; Bauerfeind P; Cilluffo T; Gonvers JJ; Savary M
    Schweiz Med Wochenschr; 1989 May; 119(21):747-51. PubMed ID: 2756403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective multivariate analysis of factors predictive of complete regression of Barrett's esophagus.
    Weston AP; Badr AS; Hassanein RS
    Am J Gastroenterol; 1999 Dec; 94(12):3420-6. PubMed ID: 10606297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrett's ulcer: response to standard dose ranitidine, high dose ranitidine, and omeprazole.
    Lee FI; Isaacs PE
    Am J Gastroenterol; 1988 Sep; 83(9):914-6. PubMed ID: 3414644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of cimetidine-resistant gastric ulcer with carbenoxolone-sodium (author's transl)].
    Simon B; Kather H; Kommerell B
    Med Klin; 1979 Aug; 74(35):1250-3. PubMed ID: 492046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptic stricture of the esophagus: report of a case with perforation and Barrett's esophagus.
    Ovartlarnporn B
    J Med Assoc Thai; 1989 Sep; 72(9):531-5. PubMed ID: 2809460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of cimetidine-treated reflux esophagitis to a Barrett's stricture.
    Saltzman M; Barwick K; McCallum RW
    Dig Dis Sci; 1982 Feb; 27(2):181-6. PubMed ID: 7075415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esophageal motor dysfunction and acid exposure in reflux esophagitis are more severe if Barrett's metaplasia is present.
    Singh P; Taylor RH; Colin-Jones DG
    Am J Gastroenterol; 1994 Mar; 89(3):349-56. PubMed ID: 8122643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cimetidine in the treatment of peptic ulcer].
    Kadish U; Leiser A; Neeman A
    Harefuah; 1980 Oct; 99(7):161-2. PubMed ID: 7203239
    [No Abstract]   [Full Text] [Related]  

  • 16. Barrett's esophagus: an old entity rediscovered.
    Mangla JC
    J Clin Gastroenterol; 1981 Dec; 3(4):347-56. PubMed ID: 7338615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled trial of carbenoxolone sodium vs. cimetidine in duodenal ulcer.
    Schenk J; Schmack B; Rösch W; Domschke W
    Scand J Gastroenterol Suppl; 1980; 65():103-7. PubMed ID: 7010527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term treatment with cimetidine and antacids in Barrett's oesophagus.
    Wesdorp IC; Bartelsman J; Schipper ME; Tytgat GN
    Gut; 1981 Sep; 22(9):724-7. PubMed ID: 7297920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus.
    Sharma P; Sampliner RE; Camargo E
    Am J Gastroenterol; 1997 Apr; 92(4):582-5. PubMed ID: 9128303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus.
    Sampliner RE
    Am J Gastroenterol; 1994 Oct; 89(10):1844-8. PubMed ID: 7942680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.